resectable pancreatic cancer

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Resectable Pancreatic Cancer Trial in Denmark (ctDNA)

Recruiting
  • Resectable Pancreatic Cancer
  • ctDNA
  • Aalborg, Denmark
  • +4 more
Mar 27, 2023

Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)

Recruiting
  • Resectable Pancreatic Cancer
  • AG Followed by FOLFIRINOX
  • Tianjin, Tianjin, China
    Rui Liu
Jan 8, 2023

Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

Terminated
  • Pancreatic Adenocarcinoma
  • +2 more
  • Germline genetic testing
  • San Francisco, California
    Invitae SF
Dec 5, 2022

Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Nab paclitaxel
  • +2 more
  • (no location specified)
Dec 5, 2022

Resectable Pancreatic Cancer, Ductal Adenocarcinoma of the Pancreas Trial in Ulm (perioperative nab-paclitaxel/gemcitabine,

Completed
  • Resectable Pancreatic Cancer
  • Ductal Adenocarcinoma of the Pancreas
  • perioperative nab-paclitaxel/gemcitabine
  • adjuvant nab-paclitaxel/gemcitabine
  • Ulm, Germany
    University of Ulm, Dept. of Internal Medicine I
Nov 21, 2022

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Loma Linda (Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic

Recruiting
  • Pancreas Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Gemcitabine 1000 mg
  • +2 more
  • Loma Linda, California
    Loma Linda University Health
Jun 14, 2022

Resectable Pancreatic Cancer Trial in Toulouse (Blood samples)

Recruiting
  • Resectable Pancreatic Cancer
  • Blood samples
  • Toulouse, France
    University Hospital
Mar 15, 2022

Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Scottsdale (Paclitaxel Protein

Active, not recruiting
  • Resectable Pancreatic Cancer
  • +3 more
  • Paclitaxel Protein Bound (Abraxane)
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 15, 2022

Resectable Pancreatic Cancer Trial in Seoul (intraoperative radiotherapy, IORT)

Recruiting
  • Resectable Pancreatic Cancer
  • intraoperative radiotherapy, IORT
  • Seoul, Korea, Republic of
    Gangnam Severance Hospital
Jan 3, 2022

Resectable Pancreatic Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Pancreatic Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Cancer of Pancreas, Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Pavia (Preoperative chemo, Preoperative

Recruiting
  • Cancer of Pancreas
  • +2 more
  • Preoperative chemotherapy
  • Preoperative radiotherapy
  • Pavia, Italy
    CNAO
Aug 31, 2021

Resectable Pancreatic Cancer Trial in Canada (Modified Folforinox (mFFX))

Recruiting
  • Resectable Pancreatic Cancer
  • Modified Folforinox (mFFX)
  • Vancouver, British Columbia, Canada
  • +7 more
Jun 24, 2021

Pancreatic Cancer, Resectable Pancreatic Cancer Trial in Tampa (Pimonidazole, Surgical Resection)

Withdrawn
  • Pancreatic Cancer
  • Resectable Pancreatic Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Feb 3, 2021

Resectable Pancreatic Cancer, Adjuvant Chemoradiotherapy, Surgery Trial in Shanghai (other, drug, radiation)

Recruiting
  • Resectable Pancreatic Cancer
  • +2 more
  • Follow-up only
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital Fudan University
Feb 1, 2021

Resectable Pancreatic Cancer Trial in Craiova, Bucharest, Cluj Napoca

Completed
  • Resectable Pancreatic Cancer
    • Craiova, Dolj, Romania
    • +4 more
    Apr 26, 2020

    Resectable Pancreatic Cancer Trial in Baltimore (Chemotherapy(FOLFIRINOX) + SBRT prior to surgery if applicable, -Oxaliplatin 85

    Completed
    • Resectable Pancreatic Cancer
    • Chemotherapy(FOLFIRINOX) + SBRT prior to surgery if applicable
    • +3 more
    • Baltimore, Maryland
      University of Maryland Medical Center
    Aug 15, 2019

    Resectable Pancreatic Cancer Trial (NGC-Triple regimen)

    Withdrawn
    • Resectable Pancreatic Cancer
    • NGC-Triple regimen
    • (no location specified)
    May 3, 2019

    Pancreatic Adenocarcinoma, Poorly Differentiated Malignant Tumor, Resectable Pancreatic Cancer Trial in Cleveland (Irinotecan

    Terminated
    • Pancreatic Adenocarcinoma
    • +8 more
    • Irinotecan Hydrochloride
    • +4 more
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jun 13, 2018

    Resectable Pancreatic Cancer, Pancreatic Ductal Carcinoma Trial in Boston (FOLFIRINOX, Gemcitabine/nab-Paclitaxel, Radiation

    Terminated
    • Resectable Pancreatic Cancer
    • Pancreatic Ductal Carcinoma
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 10, 2017

    Resectable Pancreatic Cancer Trial in United States (Gemcitabine and Abraxane)

    Completed
    • Resectable Pancreatic Cancer
    • Gemcitabine and Abraxane
    • Scottsdale, Arizona
    • +3 more
    Jun 15, 2015

    Resectable Pancreatic Cancer Trial in New Brunswick (LDE-225)

    Withdrawn
    • Resectable Pancreatic Cancer
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Dec 10, 2014